You have free access to this content

Hepatology

Cover image for Vol. 57 Issue 4

April 2013

Volume 57, Issue 4

Pages 1291–1680

  1. Editorials

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Special Article
    11. AASLD Practice Guideline
    12. New Horizons
    13. Hepatology Elsewhere
    14. Clinical Observations in Hepatology
    15. Correspondence
    16. Obituary
    1. You have free access to this content
    2. You have free access to this content
    3. You have free access to this content
    4. You have free access to this content
    5. You have free access to this content
      Hepatitis C virus promotes t-helper (Th)17 responses through thymic stromal lymphopoietin production by infected hepatocytes (pages 1314–1324)

      Hai-Chon Lee, Sung-Sang J. Sung, Peter D. Krueger, Yoon-Ah Jo, Hugo R. Rosen, Steven F. Ziegler and Young S. Hahn

      Version of Record online: 14 MAR 2013 | DOI: 10.1002/hep.26128

  2. Viral Hepatitis

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Special Article
    11. AASLD Practice Guideline
    12. New Horizons
    13. Hepatology Elsewhere
    14. Clinical Observations in Hepatology
    15. Correspondence
    16. Obituary
    1. You have free access to this content
      Chimeric hepatitis B virus/hepatitis C virus envelope proteins elicit broadly neutralizing antibodies and constitute a potential bivalent prophylactic vaccine (pages 1303–1313)

      Elodie Beaumont, Romuald Patient, Christophe Hourioux, Isabelle Dimier-Poisson and Philippe Roingeard

      Version of Record online: 14 MAR 2013 | DOI: 10.1002/hep.26132

    2. You have free access to this content
      A global view of hepatitis C: Physician knowledge, opinions, and perceived barriers to care (pages 1325–1332)

      Christopher E. McGowan, Ali Monis, Bruce R. Bacon, Josep Mallolas, Fernando L. Goncales, Ioannis Goulis, Fred Poordad, Nezam Afdhal, Stefan Zeuzem, Teerha Piratvisuth, Patrick Marcellin and Michael W. Fried

      Version of Record online: 8 APR 2013 | DOI: 10.1002/hep.26246

    3. You have free access to this content
      Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence (pages 1333–1342)

      Khayriyyah Mohd Hanafiah, Justina Groeger, Abraham D. Flaxman and Steven T. Wiersma

      Version of Record online: 4 FEB 2013 | DOI: 10.1002/hep.26141

  3. Steatohepatitis/Metabolic Liver Disease

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Special Article
    11. AASLD Practice Guideline
    12. New Horizons
    13. Hepatology Elsewhere
    14. Clinical Observations in Hepatology
    15. Correspondence
    16. Obituary
    1. You have free access to this content
      Hepatic-specific activation of peroxisome proliferator-activated receptor γ coactivator-1β protects against steatohepatitis (pages 1343–1356)

      Elena Bellafante, Stefania Murzilli, Lorena Salvatore, Dominga Latorre, Gaetano Villani and Antonio Moschetta

      Version of Record online: 14 MAR 2013 | DOI: 10.1002/hep.26222

    2. You have free access to this content
    3. You have full text access to this OnlineOpen article
      Endoplasmic reticulum stress induces hepatic steatosis via increased expression of the hepatic very low-density lipoprotein receptor (pages 1366–1377)

      Hyunsun Jo, Sung Sik Choe, Kyung Cheul Shin, Hagoon Jang, Jae Ho Lee, Je Kyung Seong, Sung Hoon Back and Jae Bum Kim

      Version of Record online: 8 APR 2013 | DOI: 10.1002/hep.26126

    4. You have free access to this content
    5. You have free access to this content
      Resistin reduces mitochondria and induces hepatic steatosis in mice by the protein kinase C/protein kinase G/p65/PPAR gamma coactivator 1 alpha pathway (pages 1384–1393)

      Lei Zhou, Xiaolan Yu, Qingjie Meng, Hongqiang Li, Congcong Niu, Yun Jiang, Yuxi Cai, Minghui Li, Qiang Li, Chaoqiang An, Le Shu, Ao Chen, Handong Su, Yin Tang, Shen Yin, Silja Raschke, Kristin Eckardt, Jürgen Eckel and Zaiqing Yang

      Version of Record online: 25 JAN 2013 | DOI: 10.1002/hep.26167

    6. You have free access to this content
      Free fatty acids repress small heterodimer partner (SHP) activation and adiponectin counteracts bile acid-induced liver injury in superobese patients with nonalcoholic steatohepatitis (pages 1394–1406)

      Lars P. Bechmann, Peri Kocabayoglu, Jan-Peter Sowa, Svenja Sydor, Jan Best, Martin Schlattjan, Anja Beilfuss, Johannes Schmitt, Rebekka A. Hannivoort, Alpaslan Kilicarslan, Christian Rust, Frieder Berr, Oliver Tschopp, Guido Gerken, Scott L. Friedman, Andreas Geier and Ali Canbay

      Version of Record online: 8 APR 2013 | DOI: 10.1002/hep.26225

  4. Hepatobiliary Malignancies

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Special Article
    11. AASLD Practice Guideline
    12. New Horizons
    13. Hepatology Elsewhere
    14. Clinical Observations in Hepatology
    15. Correspondence
    16. Obituary
    1. You have free access to this content
      FGF3/FGF4 amplification and multiple lung metastases in responders to sorafenib in hepatocellular carcinoma (pages 1407–1415)

      Tokuzo Arao, Kazuomi Ueshima, Kazuko Matsumoto, Tomoyuki Nagai, Hideharu Kimura, Satoru Hagiwara, Toshiharu Sakurai, Seiji Haji, Akishige Kanazawa, Hisashi Hidaka, Yukihiro Iso, Keiichi Kubota, Mitsuo Shimada, Tohru Utsunomiya, Masashi Hirooka, Yoichi Hiasa, Yoshikazu Toyoki, Kenichi Hakamada, Kohichiroh Yasui, Takashi Kumada, Hidenori Toyoda, Shuichi Sato, Hiroyuki Hisai, Teiji Kuzuya, Kaoru Tsuchiya, Namiki Izumi, Shigeki Arii, Kazuto Nishio and Masatoshi Kudo

      Version of Record online: 11 FEB 2013 | DOI: 10.1002/hep.25956

    2. You have free access to this content
      TIE2-expressing monocytes as a diagnostic marker for hepatocellular carcinoma correlates with angiogenesis (pages 1416–1425)

      Tokuhiro Matsubara, Tatsuya Kanto, Shoko Kuroda, Sachiyo Yoshio, Koyo Higashitani, Naruyasu Kakita, Masanori Miyazaki, Mitsuru Sakakibara, Naoki Hiramatsu, Akinori Kasahara, Yoshito Tomimaru, Akira Tomokuni, Hiroaki Nagano, Norio Hayashi and Tetsuo Takehara

      Version of Record online: 11 FEB 2013 | DOI: 10.1002/hep.25965

    3. You have free access to this content
      Resection of hepatocellular cancer ≤2 cm: Results from two Western centers (pages 1426–1435)

      Sasan Roayaie, Khaled Obeidat, Carlo Sposito, Luigi Mariani, Sherrie Bhoori, Alessandro Pellegrinelli, Daniel Labow, Josep M. Llovet, Myron Schwartz and Vincenzo Mazzaferro

      Version of Record online: 25 JAN 2013 | DOI: 10.1002/hep.25832

    4. You have free access to this content
      Contrast-enhanced intraoperative ultrasonography for vascular imaging of hepatocellular carcinoma: Clinical and biological significance (pages 1436–1447)

      Kota Sato, Shinji Tanaka, Yusuke Mitsunori, Kaoru Mogushi, Mahmut Yasen, Arihiro Aihara, Daisuke Ban, Takanori Ochiai, Takumi Irie, Atsushi Kudo, Noriaki Nakamura, Hiroshi Tanaka and Shigeki Arii

      Version of Record online: 25 JAN 2013 | DOI: 10.1002/hep.26122

    5. You have free access to this content
      Enhancement of tumor-associated antigen-specific T cell responses by radiofrequency ablation of hepatocellular carcinoma (pages 1448–1457)

      Eishiro Mizukoshi, Tatsuya Yamashita, Kuniaki Arai, Hajime Sunagozaka, Teruyuki Ueda, Fumitaka Arihara, Takashi Kagaya, Taro Yamashita, Kazumi Fushimi and Shuichi Kaneko

      Version of Record online: 8 APR 2013 | DOI: 10.1002/hep.26153

    6. You have free access to this content
      Circulating stem cell–like epithelial cell adhesion molecule–positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection (pages 1458–1468)

      Yun-Fan Sun, Yang Xu, Xin-Rong Yang, Wei Guo, Xin Zhang, Shuang-Jian Qiu, Ruo-Yu Shi, Bo Hu, Jian Zhou and Jia Fan

      Version of Record online: 4 MAR 2013 | DOI: 10.1002/hep.26151

    7. You have free access to this content
      Sal-like protein 4 (SALL4), a stem cell biomarker in liver cancers (pages 1469–1483)

      Tsunekazu Oikawa, Akihide Kamiya, Mikio Zeniya, Hiromi Chikada, Ahn Dong Hyuck, Yuji Yamazaki, Eliane Wauthier, Hisao Tajiri, Lance D. Miller, Xin Wei Wang, Lola M. Reid and Hiromitsu Nakauchi

      Version of Record online: 6 MAR 2013 | DOI: 10.1002/hep.26159

    8. You have free access to this content
      Discrete nature of EpCAM+ and CD90+ cancer stem cells in human hepatocellular carcinoma (pages 1484–1497)

      Taro Yamashita, Masao Honda, Yasunari Nakamoto, Masayo Baba, Kouki Nio, Yasumasa Hara, Sha Sha Zeng, Takehiro Hayashi, Mitsumasa Kondo, Hajime Takatori, Tatsuya Yamashita, Eishiro Mizukoshi, Hiroko Ikeda, Yoh Zen, Hiroyuki Takamura, Xin Wei Wang and Shuichi Kaneko

      Version of Record online: 18 JAN 2013 | DOI: 10.1002/hep.26168

  5. Autoimmune, Cholestatic and Biliary Disease

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Special Article
    11. AASLD Practice Guideline
    12. New Horizons
    13. Hepatology Elsewhere
    14. Clinical Observations in Hepatology
    15. Correspondence
    16. Obituary
    1. You have free access to this content
      Antimitochondrial antibody heterogeneity and the xenobiotic etiology of primary biliary cirrhosis (pages 1498–1508)

      Richy C.Y. Chen, Phornnop Naiyanetr, Shang-An Shu, Jinjun Wang, Guo-Xiang Yang, Thomas P. Kenny, Kathryn C. Guggenheim, Jeffrey D. Butler, Christopher Bowlus, Mi-Hua Tao, Mark J. Kurth, Aftab A. Ansari, Marshall Kaplan, Ross L. Coppel, Ana Lleo, M. Eric Gershwin and Patrick S.C. Leung

      Version of Record online: 29 JAN 2013 | DOI: 10.1002/hep.26157

    2. You have free access to this content
      Defective bile salt biosynthesis and hydroxylation in mice with reduced cytochrome P450 activity (pages 1509–1517)

      Cindy Kunne, Alexandra Acco, Simon Hohenester, Suzanne Duijst, Dirk R. de Waart, Alaleh Zamanbin and Ronald P.J. Oude Elferink

      Version of Record online: 18 JAN 2013 | DOI: 10.1002/hep.26133

    3. You have free access to this content
      Oxidative stress plays a major role in chlorpromazine-induced cholestasis in human HepaRG cells (pages 1518–1529)

      Sébastien Anthérieu, Pamela Bachour-El Azzi, Julie Dumont, Ziad Abdel-Razzak, Christiane Guguen-Guillouzo, Bernard Fromenty, Marie-Anne Robin and André Guillouzo

      Version of Record online: 4 MAR 2013 | DOI: 10.1002/hep.26160

    4. You have free access to this content
      Bile salt export pump is dysregulated with altered farnesoid X receptor isoform expression in patients with hepatocellular carcinoma (pages 1530–1541)

      Yuan Chen, Xiulong Song, Leila Valanejad, Alexander Vasilenko, Vijay More, Xi Qiu, Weikang Chen, Yurong Lai, Angela Slitt, Matthew Stoner, Bingfang Yan and Ruitang Deng

      Version of Record online: 15 FEB 2013 | DOI: 10.1002/hep.26187

  6. Liver Failure/Cirrhosis/Portal Hypertension

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Special Article
    11. AASLD Practice Guideline
    12. New Horizons
    13. Hepatology Elsewhere
    14. Clinical Observations in Hepatology
    15. Correspondence
    16. Obituary
    1. You have free access to this content
      Intravenous N-acetylcysteine in pediatric patients with nonacetaminophen acute liver failure: A placebo-controlled clinical trial (pages 1542–1549)

      Robert H. Squires, Anil Dhawan, Estella Alonso, Michael R. Narkewicz, Benjamin L. Shneider, Norberto Rodriguez-Baez, Dominic Dell Olio, Saul Karpen, John Bucuvalas, Steven Lobritto, Elizabeth Rand, Philip Rosenthal, Simon Horslen, Vicky Ng, Girish Subbarao, Nanda Kerkar, David Rudnick, M. James Lopez, Kathleen Schwarz, Rene Romero, Scott Elisofon, Edward Doo, Patricia R. Robuck, Sharon Lawlor, Steven H. Belle and for the Pediatric Acute Liver Failure Study Group

      Version of Record online: 4 FEB 2013 | DOI: 10.1002/hep.26001

    2. You have free access to this content
      Targeting androgen receptor in bone marrow mesenchymal stem cells leads to better transplantation therapy efficacy in liver cirrhosis (pages 1550–1563)

      Chiung-Kuei Huang, Soo Ok Lee, Kuo-Pao Lai, Wen-Lung Ma, Tzu-Hua Lin, Meng-Yin Tsai, Jie Luo and Chawnshang Chang

      Version of Record online: 8 APR 2013 | DOI: 10.1002/hep.26135

    3. You have free access to this content
      Chronic intermittent hypoxia aggravates intrahepatic endothelial dysfunction in cirrhotic rats (pages 1564–1574)

      Manuel Hernández-Guerra, Zaida Adrián de Ganzo, Yanira González-Méndez, Eduardo Salido, Pedro Abreu, Miguel Moreno, Vanesa Felipe, Beatriz Abrante and Enrique Quintero

      Version of Record online: 8 APR 2013 | DOI: 10.1002/hep.26152

  7. Liver Injury/Regeneration

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Special Article
    11. AASLD Practice Guideline
    12. New Horizons
    13. Hepatology Elsewhere
    14. Clinical Observations in Hepatology
    15. Correspondence
    16. Obituary
    1. You have free access to this content
      Increased susceptibility of natural killer T-cell-deficient mice to acetaminophen-induced liver injury (pages 1575–1584)

      Brittany V. Martin-Murphy, Douglas J. Kominsky, David J. Orlicky, Terrence M. Donohue Jr. and Cynthia Ju

      Version of Record online: 18 JAN 2013 | DOI: 10.1002/hep.26134

    2. You have free access to this content
      Roles of dendritic cells in murine hepatic warm and liver transplantation-induced cold ischemia/reperfusion injury (pages 1585–1596)

      Matthew Zhang, Shinya Ueki, Shoko Kimura, Osamu Yoshida, Antonino Castellaneta, Kikumi S. Ozaki, Anthony J. Demetris, Mark Ross, Yoram Vodovotz, Angus W. Thomson, Donna B. Stolz, David A. Geller and Noriko Murase

      Version of Record online: 8 APR 2013 | DOI: 10.1002/hep.26129

    3. You have free access to this content
      Liver grafts from CD39-overexpressing rodents are protected from ischemia reperfusion injury due to reduced numbers of resident CD4+ T cells (pages 1597–1606)

      Sandra Pommey, Bo Lu, Jennifer McRae, John Stagg, Prue Hill, Evelyn Salvaris, Simon C. Robson, Anthony J.F. d'Apice, Peter J. Cowan and Karen M. Dwyer

      Version of Record online: 14 MAR 2013 | DOI: 10.1002/hep.25985

  8. Liver Biology/Pathobiology

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Special Article
    11. AASLD Practice Guideline
    12. New Horizons
    13. Hepatology Elsewhere
    14. Clinical Observations in Hepatology
    15. Correspondence
    16. Obituary
    1. You have free access to this content
      Constitutive Notch2 signaling induces hepatic tumors in mice (pages 1607–1619)

      Michael T. Dill, Luigi Tornillo, Thorsten Fritzius, Luigi Terracciano, David Semela, Bernhard Bettler, Markus H. Heim and Jan S. Tchorz

      Version of Record online: 14 MAR 2013 | DOI: 10.1002/hep.26165

    2. You have free access to this content
      High susceptibility to liver injury in IL-27 p28 conditional knockout mice involves intrinsic interferon-γ dysregulation of CD4+ T cells (pages 1620–1631)

      Song Zhang, Ruifang Liang, Wei Luo, Chang Liu, Xiaoli Wu, Yanan Gao, Jianlei Hao, Guangchao Cao, Xi Chen, Jun Wei, Siyuan Xia, Zheng Li, Ti Wen, Yunyun Wu, Xinglong Zhou, Puyue Wang, Liqing Zhao, Zhengzhou Wu, Sidong Xiong, Xiaoming Gao, Xiang Gao, Yongyan Chen, Qing Ge, Zhigang Tian and Zhinan Yin

      Version of Record online: 12 FEB 2013 | DOI: 10.1002/hep.26166

    3. You have free access to this content
      Preexisting epithelial diversity in normal human livers: A tissue-tethered cytometric analysis in portal/periportal epithelial cells (pages 1632–1643)

      Kumiko Isse, Andrew Lesniak, Kedar Grama, John Maier, Susan Specht, Marcela Castillo-Rama, John Lunz, Badrinath Roysam, George Michalopoulos and Anthony J. Demetris

      Version of Record online: 19 MAR 2013 | DOI: 10.1002/hep.26131

  9. Special Article

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Special Article
    11. AASLD Practice Guideline
    12. New Horizons
    13. Hepatology Elsewhere
    14. Clinical Observations in Hepatology
    15. Correspondence
    16. Obituary
    1. You have free access to this content
  10. AASLD Practice Guideline

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Special Article
    11. AASLD Practice Guideline
    12. New Horizons
    13. Hepatology Elsewhere
    14. Clinical Observations in Hepatology
    15. Correspondence
    16. Obituary
    1. You have free access to this content
  11. New Horizons

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Special Article
    11. AASLD Practice Guideline
    12. New Horizons
    13. Hepatology Elsewhere
    14. Clinical Observations in Hepatology
    15. Correspondence
    16. Obituary
    1. You have free access to this content
      Natural killer cells in liver disease (pages 1654–1662)

      Zhigang Tian, Yongyan Chen and Bin Gao

      Version of Record online: 8 APR 2013 | DOI: 10.1002/hep.26115

  12. Hepatology Elsewhere

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Special Article
    11. AASLD Practice Guideline
    12. New Horizons
    13. Hepatology Elsewhere
    14. Clinical Observations in Hepatology
    15. Correspondence
    16. Obituary
    1. You have free access to this content
    2. You have free access to this content
    3. You have free access to this content
  13. Clinical Observations in Hepatology

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Special Article
    11. AASLD Practice Guideline
    12. New Horizons
    13. Hepatology Elsewhere
    14. Clinical Observations in Hepatology
    15. Correspondence
    16. Obituary
    1. You have free access to this content
      Hepatic encephalopathy in a liver transplant recipient with stable liver function (pages 1672–1674)

      Juan Pablo Arab, Luis Meneses, Rosa M. Pérez, Marco Arrese and Carlos Benítez

      Version of Record online: 8 APR 2013 | DOI: 10.1002/hep.26298

  14. Correspondence

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Special Article
    11. AASLD Practice Guideline
    12. New Horizons
    13. Hepatology Elsewhere
    14. Clinical Observations in Hepatology
    15. Correspondence
    16. Obituary
    1. You have free access to this content
    2. You have free access to this content
      Society of interventional radiology critique and commentary on the cochrane report on transarterial chemoembolization (pages 1675–1676)

      Steven C. Rose, Steven G. Kikolski, Robert G. Gish, Yuko Kono, Rohit Loomba, Alan W. Hemming, Michael J. Wallace and On behalf of the Society of Interventional Radiology

      Version of Record online: 8 APR 2013 | DOI: 10.1002/hep.26000

    3. You have free access to this content
    4. You have free access to this content
      Reply (pages 1677–1678)

      Jing H. Ngu, Richard B. Gearry and Catherine A. M. Stedman

      Version of Record online: 8 APR 2013 | DOI: 10.1002/hep.25968

    5. You have free access to this content
      Hepatitis C virus cure as motivation for alcohol withdrawal? (page 1678)

      Régine Truchi, Eve Gelsi, Faredj Cherikh, Albert Tran and Patrice Couzigou

      Version of Record online: 8 APR 2013 | DOI: 10.1002/hep.25659

  15. Obituary

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Special Article
    11. AASLD Practice Guideline
    12. New Horizons
    13. Hepatology Elsewhere
    14. Clinical Observations in Hepatology
    15. Correspondence
    16. Obituary
    1. You have free access to this content
      Jay Donald Ostrow: The yellow giant (pages 1679–1680)

      Claudio Tiribelli, Libor Vitek and Richard P. Wennberg

      Version of Record online: 8 APR 2013 | DOI: 10.1002/hep.26329

SEARCH

SEARCH BY CITATION